Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 811

1.

Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease.

Cheng S, Shah AM, Albisu JP, Desai AS, Hilkert RJ, Izzo J, Oparil S, Pitt B, Solomon SD.

J Hypertens. 2014 Sep 17. [Epub ahead of print]

PMID:
25232755
[PubMed - as supplied by publisher]
2.

Predictors of contemporary coronary artery bypass grafting outcomes.

Weisel RD, Nussmeier N, Newman MF, Pearl RG, Wechsler AS, Ambrosio G, Pitt B, Clare RM, Pieper KS, Mongero L, Reece TL, Yau TM, Fremes S, Menasché P, Lira A, Harrington RA, Ferguson TB; the RED-CABG Executive and Steering Committees.

J Thorac Cardiovasc Surg. 2014 Aug 14. pii: S0022-5223(14)01109-X. doi: 10.1016/j.jtcvs.2014.08.018. [Epub ahead of print]

PMID:
25218533
[PubMed - as supplied by publisher]
3.

Effect of Spironolactone on 30-Day Death and Heart Failure Rehospitalization (from the COACH Study).

Maisel A, Xue Y, van Veldhuisen DJ, Voors AA, Jaarsma T, Pang PS, Butler J, Pitt B, Clopton P, de Boer RA.

Am J Cardiol. 2014 Sep 1;114(5):737-42. doi: 10.1016/j.amjcard.2014.05.062. Epub 2014 Jun 19.

PMID:
25129066
[PubMed - in process]
4.

Cardiac Structure and Function and Prognosis in Heart Failure With Preserved Ejection Fraction: Findings From the Echocardiographic Study of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial.

Shah AM, Claggett B, Sweitzer NK, Shah SJ, Anand IS, O'Meara E, Desai AS, Heitner JF, Li G, Fang J, Rouleau J, Zile MR, Markov V, Ryabov V, Reis G, Assmann SF, McKinlay SM, Pitt B, Pfeffer MA, Solomon SD.

Circ Heart Fail. 2014 Sep;7(5):740-51. doi: 10.1161/CIRCHEARTFAILURE.114.001583. Epub 2014 Aug 13.

PMID:
25122186
[PubMed - in process]
5.

Spironolactone for heart failure with preserved ejection fraction.

Pfeffer MA, Pitt B, McKinlay SM.

N Engl J Med. 2014 Jul 10;371(2):181-2. doi: 10.1056/NEJMc1405715. No abstract available.

PMID:
25006726
[PubMed - indexed for MEDLINE]
Free Article
6.

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms.

Lee D, Wilson K, Akehurst R, Cowie MR, Zannad F, Krum H, van Veldhuisen DJ, Vincent J, Pitt B, McMurray JJ; for the Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure (EMPHASIS-HF) Study.

Heart. 2014 Jul 3. pii: heartjnl-2014-305673. doi: 10.1136/heartjnl-2014-305673. [Epub ahead of print]

PMID:
24993605
[PubMed - as supplied by publisher]
Free Article
7.

Geographic variation in heart failure trials: time for scepticism?

Pitt B, Gheorghiade M.

Eur J Heart Fail. 2014 Jun;16(6):601-2. doi: 10.1002/ejhf.112. Epub 2014 May 27. No abstract available.

PMID:
24865962
[PubMed - in process]
8.

'Men usually say that HIV testing is for women': gender dynamics and perceptions of HIV testing in Lesotho.

DiCarlo AL, Mantell JE, Remien RH, Zerbe A, Morris D, Pitt B, Abrams EJ, El-Sadr WM.

Cult Health Sex. 2014;16(8):867-82. doi: 10.1080/13691058.2014.913812. Epub 2014 May 22.

PMID:
24854495
[PubMed - in process]
9.

A mitochondrial pathway for biosynthesis of lipid mediators.

Tyurina YY, Poloyac SM, Tyurin VA, Kapralov AA, Jiang J, Anthonymuthu TS, Kapralova VI, Vikulina AS, Jung MY, Epperly MW, Mohammadyani D, Klein-Seetharaman J, Jackson TC, Kochanek PM, Pitt BR, Greenberger JS, Vladimirov YA, Bayır H, Kagan VE.

Nat Chem. 2014 Jun;6(6):542-52. doi: 10.1038/nchem.1924. Epub 2014 Apr 20.

PMID:
24848241
[PubMed - indexed for MEDLINE]
10.

Heart failure: the role for mineralocorticoid receptor antagonists.

Pitt B.

Swiss Med Wkly. 2014 May 20;144:w13959. doi: 10.4414/smw.2014.13959. eCollection 2014.

PMID:
24845362
[PubMed - in process]
Free Article
11.

Incidence, predictors, and outcomes related to hypo- and hyperkalemia in patients with severe heart failure treated with a mineralocorticoid receptor antagonist.

Vardeny O, Claggett B, Anand I, Rossignol P, Desai AS, Zannad F, Pitt B, Solomon SD; Randomized Aldactone Evaluation Study (RALES) Investigators.

Circ Heart Fail. 2014 Jul;7(4):573-9. doi: 10.1161/CIRCHEARTFAILURE.114.001104. Epub 2014 May 8.

PMID:
24812304
[PubMed - in process]
12.

Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study.

Montalescot G, Pitt B, Lopez de Sa E, Hamm CW, Flather M, Verheugt F, Shi H, Turgonyi E, Orri M, Vincent J, Zannad F; REMINDER Investigators; REMINDER Investigators.

Eur Heart J. 2014 Sep 7;35(34):2295-302. doi: 10.1093/eurheartj/ehu164. Epub 2014 Apr 29.

PMID:
24780614
[PubMed - in process]
13.

Developing therapies for heart failure with preserved ejection fraction: current state and future directions.

Butler J, Fonarow GC, Zile MR, Lam CS, Roessig L, Schelbert EB, Shah SJ, Ahmed A, Bonow RO, Cleland JG, Cody RJ, Chioncel O, Collins SP, Dunnmon P, Filippatos G, Lefkowitz MP, Marti CN, McMurray JJ, Misselwitz F, Nodari S, O'Connor C, Pfeffer MA, Pieske B, Pitt B, Rosano G, Sabbah HN, Senni M, Solomon SD, Stockbridge N, Teerlink JR, Georgiopoulou VV, Gheorghiade M.

JACC Heart Fail. 2014 Apr;2(2):97-112. doi: 10.1016/j.jchf.2013.10.006.

PMID:
24720916
[PubMed - in process]
14.

Spironolactone for heart failure with preserved ejection fraction.

Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM; TOPCAT Investigators.

N Engl J Med. 2014 Apr 10;370(15):1383-92. doi: 10.1056/NEJMoa1313731.

PMID:
24716680
[PubMed - indexed for MEDLINE]
15.

Effect of eplerenone in percutaneous coronary intervention-treated post-myocardial infarction patients with left ventricular systolic dysfunction: a subanalysis of the EPHESUS trial.

Iqbal J, Fay R, Adlam D, Squire I, Parviz Y, Gunn J, Pitt B, Zannad F.

Eur J Heart Fail. 2014 Jun;16(6):685-91. doi: 10.1002/ejhf.88. Epub 2014 Apr 4.

PMID:
24706498
[PubMed - in process]
16.

Heart failure with systolic dysfunction complicating acute myocardial infarction - differential outcomes but similar eplerenone efficacy by ST-segment or non-ST-segment elevation: A post hoc substudy of the EPHESUS trial.

Carillo S, Zhang Y, Fay R, Angioi M, Vincent J, Sutradhor SC, Ahmed A, Pitt B, Zannad F.

Arch Cardiovasc Dis. 2014 Mar;107(3):149-57. doi: 10.1016/j.acvd.2014.01.010. Epub 2014 Mar 11.

PMID:
24630753
[PubMed - in process]
17.

Decongestion in acute heart failure.

Mentz RJ, Kjeldsen K, Rossi GP, Voors AA, Cleland JG, Anker SD, Gheorghiade M, Fiuzat M, Rossignol P, Zannad F, Pitt B, O'Connor C, Felker GM.

Eur J Heart Fail. 2014 May;16(5):471-82. doi: 10.1002/ejhf.74. Epub 2014 Mar 5.

PMID:
24599738
[PubMed - in process]
18.

'There's no place like home': perceptions of home-based HIV testing in Lesotho.

Mantell JE, DiCarlo AL, Remien RH, Zerbe A, Morris D, Pitt B, Nkonyana JP, Abrams EJ, El-Sadr W.

Health Educ Res. 2014 Jun;29(3):456-69. doi: 10.1093/her/cyu004. Epub 2014 Mar 5.

PMID:
24599266
[PubMed - in process]
19.

The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunction.

Ketchum ES, Dickstein K, Kjekshus J, Pitt B, Wong MF, Linker DT, Levy WC.

Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):46-55. doi: 10.1177/2048872613502283. Epub 2013 Sep 11.

PMID:
24562803
[PubMed - in process]
Free PMC Article
20.

Improved spatial resolution of matrix-assisted laser desorption/ionization imaging of lipids in the brain by alkylated derivatives of 2,5-dihydroxybenzoic acid.

Stoyanovsky DA, Sparvero LJ, Amoscato AA, He RR, Watkins S, Pitt BR, Bayir H, Kagan VE.

Rapid Commun Mass Spectrom. 2014 Mar 15;28(5):403-12. doi: 10.1002/rcm.6796.

PMID:
24497278
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk